Copper, Pfizer, and AUD/USD Gain Ground as Confidence Improves
Market confidence is improving across several key assets, but the outlook is still mixed. Copper is benefiting from stronger risk appetite, long-term demand from electrification, and supply concerns, while Pfizer is showing signs of recovery as its non-COVID business grows. At the same time, AUD/USD is gaining support from Australia's higher interest-rate outlook and a softer US dollar.
Still, caution is needed. High copper inventories, falling COVID-related sales at Pfizer, patent competition, and global uncertainty could all limit further upside. Overall, the market tone is more positive than before, but the next move will depend on demand, inflation, interest rates, and broader confidence.